• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-506 是喉鳞状细胞癌中依赖 YAP1 的肿瘤抑制因子。

miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma.

机构信息

a Department of Otolaryngology Head and Neck Surgery , the First Affiliated Hospital of Zhengzhou University , Zhengzhou City , Henan Province , P. R. China.

出版信息

Cancer Biol Ther. 2019;20(6):826-836. doi: 10.1080/15384047.2018.1564569. Epub 2019 Mar 25.

DOI:10.1080/15384047.2018.1564569
PMID:30907227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6606012/
Abstract

Laryngeal squamous cell carcinoma (LSCC) accounts for 95% of laryngeal cancer incidence. Tobacco use has been shown to have a linear association with the development of the disease. While early diagnosis and treatment of LSCC are critical in improving the 5-year survival rate and quality of life, diagnosis of early-stage LSCC remains challenging because of the unapparent symptoms. Here, we report that miR-506, a critical regulator in many types of cancers, is aberrantly suppressed in LSCC patient tissues and cultured cancer cells. This is likely responsible for the enhanced production of YAP1 protein, a transcriptional factor that is well known for its oncogenic roles in LSCC malignancy. Statistical analysis has confirmed that the expression levels of miR-506 and YAP1 are strongly correlated with the malignant statuses of patient tumors. Restoring the expression level of miR-506 in cultured LSCC cells significantly inhibited proliferation, migration and invasion of the cells. The miR-506 and YAP1 regulatory network seems to affect at least pathways involved in apoptosis. Our study, for the first time, has demonstrated a tumor suppressive role of miR-506 in LSCC. This opens new opportunities for further exploring the molecular details of the development of the disease and thus will facilitate the development of novel diagnosis and therapeutic strategies.

摘要

喉鳞状细胞癌(LSCC)占喉癌发病率的 95%。吸烟已被证明与疾病的发生呈线性相关。虽然早期诊断和治疗 LSCC 对于提高 5 年生存率和生活质量至关重要,但由于早期 LSCC 症状不明显,诊断仍然具有挑战性。在这里,我们报告 miR-506 是多种癌症的关键调节因子,在 LSCC 患者组织和培养的癌细胞中异常抑制。这可能导致 YAP1 蛋白的产生增强,YAP1 是一种转录因子,其在 LSCC 恶性肿瘤中的致癌作用是众所周知的。统计分析证实 miR-506 和 YAP1 的表达水平与患者肿瘤的恶性状态密切相关。在培养的 LSCC 细胞中恢复 miR-506 的表达水平显著抑制了细胞的增殖、迁移和侵袭。miR-506 和 YAP1 调控网络似乎至少影响了涉及细胞凋亡的途径。我们的研究首次证明了 miR-506 在 LSCC 中的肿瘤抑制作用。这为进一步探索疾病发展的分子细节提供了新的机会,从而将有助于开发新的诊断和治疗策略。

相似文献

1
miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma.miR-506 是喉鳞状细胞癌中依赖 YAP1 的肿瘤抑制因子。
Cancer Biol Ther. 2019;20(6):826-836. doi: 10.1080/15384047.2018.1564569. Epub 2019 Mar 25.
2
The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.SNHG3 的敲低通过 miR-340-5p/YAP1 轴和 Wnt/β-连环蛋白通路抑制喉鳞状细胞癌的进展。
Neoplasma. 2020 Sep;67(5):1094-1105. doi: 10.4149/neo_2020_191022N1073. Epub 2020 Jun 16.
3
Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.环状 RNA_100290 的过表达通过 miR-136-5p/RAP2C 轴促进喉鳞状细胞癌的进展。
Biomed Pharmacother. 2020 May;125:109874. doi: 10.1016/j.biopha.2020.109874. Epub 2020 Jan 31.
4
Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.长链非编码 RNA PVT1 通过作为分子海绵调节 miR-519d-3p 促进喉鳞状细胞癌的发展。
J Cell Biochem. 2019 Mar;120(3):3911-3921. doi: 10.1002/jcb.27673. Epub 2018 Oct 10.
5
MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma.miRNA-195 与调控人喉鳞状细胞癌的病理生理过程有关。
Mol Med Rep. 2018 Apr;17(4):5283-5291. doi: 10.3892/mmr.2018.8523. Epub 2018 Jan 31.
6
RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.RUNX3在miR-148a-3p/DNMT1轴的调控下抑制喉鳞状细胞癌的恶性进展。
Cell Biochem Funct. 2016 Dec;34(8):597-605. doi: 10.1002/cbf.3233. Epub 2016 Nov 15.
7
circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.环状 PAR 结构域蛋白 3 通过抑制自噬,经蛋白激酶 C Ⅰ-Akt-雷帕霉素靶蛋白通路促进喉鳞状细胞癌的恶性进展和化疗耐药。
Mol Cancer. 2020 Nov 24;19(1):166. doi: 10.1186/s12943-020-01279-2.
8
Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.长链非编码RNA LOC554202通过调控miR-31促进喉鳞状细胞癌进展。
J Cell Biochem. 2018 Aug;119(8):6953-6960. doi: 10.1002/jcb.26902. Epub 2018 May 8.
9
CircPRRC2C Promotes the Oncogenic Phenotypes of Laryngeal Squamous Cell Carcinoma Cells via MiR-136-5p/HOXD11 Axis.环状 RNA PRRC2C 通过 miR-136-5p/HOXD11 轴促进喉鳞状细胞癌细胞的致癌表型。
Mol Biotechnol. 2024 Sep;66(9):2381-2395. doi: 10.1007/s12033-023-00868-y. Epub 2023 Sep 20.
10
Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.miR-129-5p的上调通过影响STAT3表达来影响喉癌细胞的增殖、侵袭和迁移。
Tumour Biol. 2016 Feb;37(2):1789-96. doi: 10.1007/s13277-015-3969-y. Epub 2015 Aug 29.

引用本文的文献

1
Study of MicroRNA Cluster Located on Chromosome X in Serum and Breast Cancer Tissue.X 染色体上微小 RNA 簇在血清和乳腺癌组织中的研究。
Biochem Genet. 2024 Apr;62(2):1115-1135. doi: 10.1007/s10528-023-10448-z. Epub 2023 Aug 6.
2
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.微小RNA在喉癌患者中的诊断和预后价值:一项系统评价
Noncoding RNA. 2023 Jan 19;9(1):9. doi: 10.3390/ncrna9010009.
3
YY1 accelerates oral squamous cell carcinoma progression through long non-coding RNA Kcnq1ot1/microRNA-506-3p/SYPL1 axis.YY1 通过长非编码 RNA Kcnq1ot1/miRNA-506-3p/SYPL1 轴加速口腔鳞状细胞癌的进展。
J Ovarian Res. 2022 Jul 1;15(1):77. doi: 10.1186/s13048-022-01000-5.
4
Role of the Long Intergenic Non-Protein-Coding RNA 1278/miR-185-5p/Cystatin SN Axis in Laryngeal Cancer Cells.长链基因间非编码RNA 1278/miR-185-5p/胱抑素SN轴在喉癌细胞中的作用
J Oncol. 2022 Apr 21;2022:6406943. doi: 10.1155/2022/6406943. eCollection 2022.
5
Identification of Novel Prognostic Markers Associated With Laryngeal Squamous Cell Carcinoma Using Comprehensive Analysis.通过综合分析鉴定与喉鳞状细胞癌相关的新型预后标志物
Front Oncol. 2022 Jan 11;11:779153. doi: 10.3389/fonc.2021.779153. eCollection 2021.
6
ChrXq27.3 miRNA cluster functions in cancer development.ChrXq27.3 微小 RNA 簇在癌症发生发展中发挥作用。
J Exp Clin Cancer Res. 2021 Mar 25;40(1):112. doi: 10.1186/s13046-021-01910-0.
7
miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1β.微小RNA-375-3p通过靶向肝细胞核因子-1β抑制喉鳞状细胞癌的进展。
Oncol Lett. 2020 Oct;20(4):80. doi: 10.3892/ol.2020.11941. Epub 2020 Aug 3.
8
Identification of core miRNA prognostic markers in patients with laryngeal cancer using bioinformatics analysis.基于生物信息学分析鉴定喉癌患者的核心 miRNA 预后标志物。
Eur Arch Otorhinolaryngol. 2021 May;278(5):1613-1626. doi: 10.1007/s00405-020-06275-2. Epub 2020 Aug 12.

本文引用的文献

1
Metazoan MicroRNAs.后生动物 MicroRNAs。
Cell. 2018 Mar 22;173(1):20-51. doi: 10.1016/j.cell.2018.03.006.
2
Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.YAP1激活在头颈部鳞状细胞癌中的临床意义
Oncotarget. 2017 Nov 27;8(67):111130-111143. doi: 10.18632/oncotarget.22666. eCollection 2017 Dec 19.
3
Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.Yes 相关蛋白的高表达与喉鳞状细胞癌的恶性状态和预后相关。
Mol Med Rep. 2017 Oct;16(4):4934-4940. doi: 10.3892/mmr.2017.7187. Epub 2017 Aug 7.
4
Expression and clinical significance of YAP in laryngeal squamous cell carcinoma patients.YAP在喉鳞状细胞癌患者中的表达及临床意义
Oncol Lett. 2017 Mar;13(3):1311-1314. doi: 10.3892/ol.2016.5541. Epub 2016 Dec 27.
5
An update on larynx cancer.喉癌研究进展。
CA Cancer J Clin. 2017 Jan;67(1):31-50. doi: 10.3322/caac.21386. Epub 2016 Nov 29.
6
The emerging role of miR-506 in cancer.微小RNA-506在癌症中的新作用。
Oncotarget. 2016 Sep 20;7(38):62778-62788. doi: 10.18632/oncotarget.11294.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
The role of microRNAs expression in laryngeal cancer.微小RNA表达在喉癌中的作用。
Oncotarget. 2015 Sep 15;6(27):23297-305. doi: 10.18632/oncotarget.4195.
9
MicroRNAs in cancer: biomarkers, functions and therapy.微小 RNA 与癌症:生物标志物、功能与治疗。
Trends Mol Med. 2014 Aug;20(8):460-9. doi: 10.1016/j.molmed.2014.06.005. Epub 2014 Jul 12.
10
Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.喉癌风险与核苷酸切除修复通路基因 ERCC1、ERCC2、ERCC3、ERCC4、ERCC5 和 XPA 中的常见单核苷酸多态性。
Gene. 2014 May 25;542(1):64-8. doi: 10.1016/j.gene.2014.02.043. Epub 2014 Feb 26.